Skip to main content

Table 3 Median survival time of LILRB low- and high-expression liver patients in OS, RFS, PFS, and DSS (Kaplan–Meier plots)

From: Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer

Survival outcome Expression (month)a LILRB1 LILRB2 LILRB3 LILRB4 LILRB5
OS Low-expression cohort 46.60 30.00 54.10 104.20 25.60
High-expression cohort 56.50 71.00 70.50 49.70 70.50
RFS Low-expression cohort 21.87 14.33 21.93 21.30 10.50
High-expression cohort 47.73 37.23 47.73 47.73 34.40
PFS Low-expression cohort 16.73 12.80 19.53 16.83 10.50
High-expression cohort 30.40 30.10 37.67 36.10 29.30
DSS Low-expression cohort 84.73 40.33 104.17 31.03 37.83
High-expression cohort 84.40 84.73 70.53 33.50 84.73
  1. aThe cutoff values distinguished by low expression and high expression were computed by the Kaplan–Meier Plotter